ALOX5 and neoplasm: Analysis of individual patient's tumor/normal ratio of Alox5 and 5‐HETE showed that all patients who displayed significant upregulation of ALOX5 also demonstrated higher level of 5‐HETE, except patients #6, #10, #11, #21, #26, #36, and #49 (Figure 1D).